ArticleGels (Basel, Switzerland)2025
Novel GelMA/GelMA-AEMA Hydrogel Blend with Enhanced Printability as a Carrier for iPSC-Derived Chondrocytes In Vitro.
Article in Gels (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quantitative Assessment of Hydrogel Printability in Extrusion Bioprinting.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cartilage tissue engineering aims to restore damaged cartilage using biomaterials, cells, and/or biological cues to support cell growth and tissue repair. Although in the past decades scientific advances have moved the field forward, their translation to a clinical setting is still hampered. One major hurdle to take is to reduce process variability to ensure a predictable biological outcome. Using enabling technologies such as bioprinting has shown the potential to improve process robustness. However, developing bioinks that balance printability with biological functionality remains a major challenge. This study presents the development and structure-property relationships of a novel gelatin-based hydrogel blend, GelMA/GelMA-AEMA, optimized for extrusion-based bioprinting (EBB) while maintaining the crucial biological properties of GelMA for tissue engineering applications. The novel GelMA/GelMA-AEMA blend demonstrated superior flowability and printability compared to GelMA, effectively addressing common 3D-printing defects such as filament shape inhomogeneity. A systematic rheological characterization revealed that the blend exhibits a softer, elastically dominated structure with improved compliance. The blend behaves as a yield-stress fluid with a strong shear-thinning degree, making it highly suitable for EBB. The superior flow properties of the blend are deemed to enhance bond slippage and stress-induced orientation of its more imperfect gel structure, resulting in greater macroscopic deformation and enhanced print fidelity. In addition, histological assessment of a 21-day in vitro study with iPSC-derived chondrocytes suggested that the blend is at least equally performant as GelMA in supporting matrix formation. Histological analysis shows similar matrix deposition profiles, whereas gene expression analysis and compression tests even have suggested superior characteristics for cartilage TE. This study emphasizes the central role of rheology in bioink development and provides foundations for future material development for EBB, with potential implications for cartilage tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.